Skip to main content
Pharming Group N.V. logo

Pharming Group N.V. — Investor Relations & Filings

Ticker · PHARM ISIN · NL0010391025 LEI · 724500DCJ9MPG74JEH91 AS Manufacturing
Open in API
Filings indexed 800 across all filing types
Latest filing 2012-05-15 Share Issue/Capital Cha…
Country NL Netherlands
Listing AS PHARM

About Pharming Group N.V.

https://www.pharming.com/

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.

Recent filings

Filing Released Lang Actions
Pharming redeems fifth tranche of convertible bond
Share Issue/Capital Change Classification · 99% confidence The document announces a specific corporate action: the redemption of a tranche of a convertible bond, resulting in the issuance of new shares and an increase in the total outstanding share count. This action directly relates to the company's capital structure and financing activities. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it covers updates on financing activities and capital structure changes. It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as the content is highly specific to a financing event.
2012-05-15 English
Pharming reports on Annual General Meeting of Shareholders
AGM Information Classification · 99% confidence The document is explicitly titled "PHARMING REPORTS ON ANNUAL GENERAL MEETING OF SHAREHOLDERS" and details that at the AGM held on May 14, 2012, all proposals were approved, including capital structure changes. This directly relates to the proceedings and outcomes of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). Although it mentions that presentation slides are available, the core content is the report/summary of the AGM results, not just an announcement of a report's availability (RPA).
2012-05-15 English
Pharming reports financial results first quarter 2012
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first quarter of 2012, titled 'PHARMING REPORTS FINANCIAL RESULTS FIRST QUARTER 2012'. It includes detailed financial highlights, operational updates, and full condensed consolidated interim financial statements (Statement of Financial Position, Statement of Income, etc.). It is not merely an announcement of a report, as it contains the actual financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). Q1 2012
2012-04-26 English
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first quarter of 2012, titled 'PHARMING REPORTS FINANCIAL RESULTS FIRST QUARTER 2012'. It includes detailed financial highlights, operational updates, and full condensed consolidated interim financial statements (Statement of Financial Position, Statement of Income, etc.). It is not merely an announcement of a report, as it contains the actual financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). Q1 2012
2012-04-26 English
Pharming launches free investor relations app
Regulatory Filings Classification · 95% confidence The document is a short press release dated April 18, 2012, announcing the launch of a new Investor Relations (IR) mobile application for iPod, iPhone, and iPad. It details the features of the app, which include access to press releases, AFM filings, corporate information, and stock quotes. Since the document is an announcement about a new tool for accessing corporate information rather than the financial report itself (like a 10-K or IR), and it is not a standard regulatory filing like a DIRS or DIV, it fits best under the category of general corporate communication related to investor access. Given the options, this is a general announcement that doesn't fit the specific financial report types (10-K, IR, ER, etc.). It is an announcement about improving investor communication, which is often categorized under general regulatory/investor relations announcements. Since it is not a specific report type, and it is an announcement, the most appropriate general category is Regulatory Filings (RNS) as a fallback for miscellaneous corporate announcements, although it is primarily an IR announcement. However, looking closely at the definitions, it is an announcement about corporate information access, not a report itself. It is not a proxy solicitation (PSI), dividend notice (DIV), or management change (MANG). Given its nature as a press release announcing a new IR tool, RNS (Regulatory Filings/Miscellaneous) is the best fit among the provided codes for a non-standard announcement.
2012-04-18 English
Pharming redeems fourth tranche of convertible bond
Capital/Financing Update Classification · 99% confidence The document is a press release dated April 11, 2012, announcing that Pharming Group NV has redeemed the fourth tranche of its convertible bond, detailing the number of shares issued, and confirming the ongoing redemption schedule. This announcement concerns a specific corporate financing activity (redemption of debt via equity issuance). This aligns directly with the definition of 'Capital/Financing Update' (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it pertains to a specific financing event.
2012-04-11 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.